Braeger Matthew R
Known title: Executive Vice PresidentCIK: 0001721131
Associated companies
Transaction History
| ASB | ▼ Sell | Open Market | 4,000 | $113K | 6/9/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 1,000 | $28K | 6/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,444 | $61K | 3/9/2026 | View on chart |
| ASB | ▲ Buy | Grant | 5,200 | $130K | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 809 | $24K | 2/8/2026 | View on chart |
| ASB | ▲ Buy | Grant | 1,484 | $40K | 2/1/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 2,000 | $53K | 9/9/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,456 | $31K | 3/10/2025 | View on chart |
| ASB | ▲ Buy | Grant | 3,097 | $66K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 822 | $21K | 2/10/2025 | View on chart |
| ASB | ▲ Buy | Grant | 1,588 | $0 | 1/29/2025 | View on chart |
| ASB | ▼ Sell | Open Market | 25,923 | $691K | 11/8/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 7,911 | $192K | 11/8/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 2,435 | $54K | 11/8/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 15,577 | $317K | 11/8/2024 | View on chart |
| ASB | ▼ Sell | Other | 744 | $20K | 11/7/2024 | View on chart |
| ASB | ▲ Buy | Grant | 3,497 | $72K | 3/13/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,644 | $34K | 3/13/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 858 | $17K | 2/9/2024 | View on chart |
| ASB | ▲ Buy | Grant | 1,744 | $0 | 1/30/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 675 | $16K | 2/9/2023 | View on chart |
| ASB | ▲ Buy | Grant | 1,736 | $0 | 1/30/2023 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,451 | $33K | 1/27/2023 | View on chart |
| ASB | ▲ Buy | Grant | 3,885 | $88K | 1/26/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.